Make follow-up measurable when the scale can’t tell the whole story.
Peptide and GLP-1 clinics need disciplined documentation, not bigger promises. Peptodyssey gives clinics structured screening and biomarker-tracking workflows so providers can document follow-up rationale, review trends over time, and keep patients engaged without moving patient data through a marketing funnel.
Clinics lose patients when follow-up is hard to explain
GLP-1 programs often have a familiar measurement anchor: weight over time. Other peptide and wellness protocols can be harder to discuss with patients because the relevant markers, cadence, and rationale vary by clinic workflow. When that record is scattered, the next visit becomes harder to earn.
Thin intake structure
Many clinics collect useful patient context, but not always in a repeatable format that makes the starting plan easy to explain later.
Beyond the scale
Some protocols need a broader follow-up record than weight alone. Without a defined cadence, a visit can depend too heavily on memory and subjective check-ins.
No documented rationale
As oversight of the category evolves, clinics need clearer records showing what was reviewed, why a follow-up was scheduled, and what the provider considered.
Personalize, then track
Screen before the first protocol
Structured intake and screening help a clinic collect the same baseline context consistently before the treating provider makes a clinical decision.
Turn each follow-up into a record
A structured biomarker cadence gives the clinic a comparable record behind the next visit and helps patients understand what is being monitored.
The outcome record supports provider review over time. Peptodyssey does not recommend treatment or claim efficacy; it organizes the data the clinic chooses to track.
Earn the right clinic conversations, then retain with structure
Peptodyssey is primarily retention software. Clinic acquisition comes later, after a clinic can show a disciplined process: clear intake, documented follow-up, and outcome records the clinic owns.
Target clinics with real fit
We focus on independent, cash-pay clinics that already have patient demand, steady revenue, and a reason to improve follow-up. That keeps the conversation grounded in fit, not volume for its own sake.
Lead with proof, not a pitch
Before any pilot conversation, we bring a clinic-specific view of where retention, documentation, and workflow gaps appear. The offer starts with evidence and a scoped pilot, not a generic sales deck.
Case studies come after measurement
Only after a pilot has baseline data and documented follow-up can the clinic decide what is appropriate to share as a case study or testimonial.
Every bit of this is designed around your clinic’s own data. Peptodyssey is the software and workflow layer. We do not sell or broker patients, and the public demo form collects clinic contact information only.
Retention starts with a repeatable follow-up process
Cash-pay clinics depend on trust over time. When follow-up is structured and documented, patients and providers have a clearer conversation about what happens next. Peptodyssey supports that retention workflow as software for the clinic.
Built as workflow software, reviewed before clinical use
This site is authored by Florida Man Bioscience for clinic operators and investors. Public pages are business/product materials, not clinical guidance. Any protocol logic, biomarker cadence, or genomic interpretation used in a pilot must be reviewed with licensed clinical leadership, documented in the clinic workflow, and supported by the clinic’s own compliance process.
Clinical review status: pending. Protocol logic and biomarker cadence are reviewed with licensed clinical leadership before any pilot deployment. We have not engaged a named medical reviewer for these public pages yet; once one is engaged, that reviewer’s name and credential will be published here. We do not list a credential we do not have.